Sprint Bioscience Balance Sheet Health
Financial Health criteria checks 5/6
Sprint Bioscience has a total shareholder equity of SEK13.5M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK46.0M and SEK32.5M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 31.72m |
| Equity | SEK 13.48m |
| Total liabilities | SEK 32.54m |
| Total assets | SEK 46.03m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: SPRINT's short term assets (SEK41.7M) exceed its short term liabilities (SEK32.5M).
Long Term Liabilities: SPRINT has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: SPRINT is debt free.
Reducing Debt: SPRINT had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SPRINT has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if SPRINT has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.